PAI-1 (Plasminogen Activator Inhibitor-1)
Here’s what it reflects — and what to do about it.
Longetic pulls together every lab and record you’ve had, follows how PAI-1 (Plasminogen Activator Inhibitor-1) changes over time, and explains what’s shifting — so you walk into your next appointment prepared, with reminders for retests along the way.
What is PAI-1 (Plasminogen Activator Inhibitor-1)?
A protein that slows clot breakdown; studied as a marker relevant to inflammation and cardiovascular clotting balance.
Plasminogen activator inhibitor-1 (PAI-1) is a protein that inhibits the enzymes responsible for breaking down blood clots, making it a key regulator of the body's clot-dissolving (fibrinolytic) system. It relates to both the cardiovascular and immune systems, since PAI-1 is produced by fat tissue, blood vessel lining cells, and immune cells, and its levels tend to rise during inflammation. Researchers have studied PAI-1 in relation to cardiovascular risk, metabolic health, and clotting balance, as higher levels may be linked with reduced clot breakdown. Clinicians may consider PAI-1 testing in research or specialized settings when evaluating unexplained clotting tendencies or as part of broader cardiovascular risk assessment, though it is not a routine screening test for most people. Results are always interpreted alongside other clotting and cardiovascular markers rather than as a stand-alone measure.
Lifestyle factors that influence this marker
- Maintain a balanced, anti-inflammatory diet emphasizing vegetables, fruit, fiber, and healthy fats
- Engage in regular aerobic exercise, which is associated with more favorable fibrinolytic balance
- Work toward a comfortable body weight, since PAI-1 is produced by fat tissue
- Prioritize consistent, adequate sleep
- Avoid smoking, which may influence clotting and inflammatory pathways
- Limit alcohol intake to moderate levels
- Manage stress through relaxation or mindfulness practices
Tests often checked alongside this
- D-dimer — reflects clot breakdown activity from the opposite side of the fibrinolytic system
- Fibrinogen — a related clotting protein often assessed together
- CRP — a general marker of inflammation that can influence PAI-1
- Lipid panel — often considered together in cardiovascular risk assessment
How this can show up in how you look and feel
- May be associated with a tendency toward reduced clot breakdown in some contexts
- May be associated with metabolic or cardiovascular risk factors when persistently elevated
What can affect this marker
- Age
- Sex
- Inflammation
- Exercise
- Lab variability between assays
What to track over time
- How levels trend alongside other cardiovascular and clotting markers
- Whether changes correlate with weight, activity level, or metabolic health over time
- Repeat testing may be considered if it is part of an ongoing cardiovascular risk evaluation
What to ask your doctor
- Why was PAI-1 included in my testing panel?
- How does this fit with my broader cardiovascular risk picture?
- Are there lifestyle changes that could help support healthy clotting balance?
- Should this be followed over time or was it a one-time check?
This glossary entry is for informational purposes only and is not a substitute for professional medical advice. Read our Terms of Use.
References
About our sources
Official sources
Government health agencies, national institutes, and intergovernmental bodies whose guidelines carry regulatory or policy weight.
Clinical / professional
Medical societies, specialty colleges, and professional associations whose consensus statements reflect clinical practice standards.
Peer-reviewed research
Original research articles and systematic reviews published in indexed journals and verified through PubMed or DOI.